1. Italy Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
Garofalo Health Care S.P.A.

Garofalo Health Care S.P.A.

5.36
EUR
0.00
(0.00%)
0.22EPS
24.52P/E
470.42MMarket Cap
Dec 02Next Earn
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.57
1.55
2.27
1.88
2.4
2.58
3.17
3.6
4.13
5.17
5.48
5.58
Basic EPS, GAAP
0.08
0.07
0.2
0.17
0.16
0.14
0.21
0.24
0.23
0.24
0.26
0.22
Free Cash Flow per Basic Share
0.13
0.09
0.4
0.11
0.12
0.13
0.13
0.33
0.37
0.15
0.18
0.14
Dividend per Share
0.11
0.01
0.01
- -
- -
- -
- -
- -
- -
- -
0.09
- -
Book Value per Share
0.92
0.96
1.19
2.18
2.35
2.49
2.92
3.14
3.38
3.64
3.84
3.92
Tangible Book Value per Share
0.65
0.68
0.53
1.54
0.19
0.11
-0.06
-0.09
-0.86
-0.57
-0.39
-0.44
Basic Weighted Avg Shares
80
80
60
82
82
82
89
89
89
90
89
88
Sales/Revenue/Turnover
126
124
136
154
196
210
283
320
366
468
485
493
Operating Margin (%)
11.17
9.27
14.07
13.59
12.98
9.43
11.86
11.7
12.7
11.73
11.37
10.8
Depreciation Expense
5
5
6
6
10
12
16
18
21
25
28
29
Net Income, GAAP
7
5
12
14
13
12
19
21
21
22
23
19
Effective Tax Rate (%)
39.06
37.35
27.66
21.98
29.51
9.51
21.45
21.69
27.85
28.8
30.61
30.68
Profit Margin (%)
5.25
4.43
9.01
8.8
6.7
5.6
6.66
6.69
5.68
4.64
4.83
3.89
Working Capital
15
14
12
78
11
2
- -
-10
-59
20
31
2
LT Debt
30
26
35
23
92
90
138
132
164
223
220
215
Total Equity
76
79
102
186
192
203
261
279
301
333
350
357
Return on Invested Capital (%)
- -
5.12
10.03
7.74
5.33
4.4
5.77
5.51
5.77
5.79
5.53
4.63
Return on Capital (%)
- -
4.96
9.5
7.33
5.35
4.4
5.75
5.49
5.72
5.77
5.41
4.52
Return on Common Equity (%)
- -
7.29
14.23
9.91
7.09
5.96
8.12
7.94
7.2
6.99
7.08
5.64

Capital Structure

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
6
8
28
LT Borrowings
200
228
198
LT Finance Leases
19
- -
17
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
88
88
88
Market Capitalization
490
410
470

Working Capital

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
168
178
176
Cash, Cash Equivalents & STI
30
27
25
Accounts Receivable, Net
118
128
131
Inventories
6
6
6
Total Current Liabilities
137
155
174
Payables & Accruals
- -
- -
- -
ST Debt
6
8
28
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
18.31%
11.77%
5%
Free Cash Flow
28.67%
25.19%
15.72%
Net Income, GAAP
18.63%
16.58%
7.87%
Sales/Revenue/Turnover
14.95%
18.72%
3.71%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
126
121
100
120
468
2025
129
126
108
122
485
2026
133
130
- -
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.11
0.1
- -
0.04
0.24
2025
0.11
0.11
0.04
- -
0.26
2026
0.1
0.08
- -
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.09
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Maria Laura Garofalo
Full Time Employees
2,714
Sector
Health services
Industry
Hospital/Nursing management
Address
Rome Italy
IPO Date
Nov 9, 2018
Website
garofalohealthcare.com
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
Garofalo Health Care S.p.A. is an Italy-based healthcare provider that operates an integrated network of private accredited hospitals, specialized clinics, diagnostic centers, and residential health and social care facilities. The company operates through two main business segments: the Hospital Sector and the Social Services and Dependency Care Sector. Its comprehensive medical and healthcare services include medium- and high-complexity general and specialized surgery; robotic-assisted surgery; emergency medicine and acute hospital admissions; interventional cardiology and cardiac surgery; orthopedic, neurosurgical, and oncological treatments; motor, neurological, cardiac, and nutritional post-acute rehabilitation; outpatient medical and clinical consultations; comprehensive diagnostic imaging, including magnetic resonance imaging, computed tomography, and positron emission tomography; clinical laboratory testing; residential social assistance care through Residenze Sanitarie Assistenziali; and specialized long-term residential treatment for patients in vegetative states or with chronic neurodegenerative conditions. Garofalo Health Care S.p.A. serves patients under the Italian National Health Service framework as well as private-paying patients and health insurance policyholders across Northern and Central Italy, maintaining accredited facilities across Piedmont, Lombardy, Veneto, Friuli Venezia Giulia, Liguria, Emilia-Romagna, Tuscany, and Lazio. Founded in the 1950s and headquartered in Rome, Italy, the company is listed on the Euronext STAR segment of Borsa Italiana. In recent corporate developments, the company has pursued strategic expansion and territorial consolidation through targeted acquisitions and operational investments. Recent transactions include the acquisition and integration of the Aurelia Hospital Group, comprising Aurelia Hospital and European Hospital in Rome; the acquisition of Sanatorio Triestino in Trieste; the acquisition of Casa di Cura Città di Roma to strengthen its central Italian hospital hub; an agreement to acquire a controlling majority stake in Domus Nova S.p.A. in Ravenna; and continuous multi-facility upgrades focusing on advanced surgical robotics, diagnostic infrastructure, and expanded capacity.